Company news
RepliCel Life Sciences Inc. news in 2017
RepliCel Life Sciences Inc.'s news releases, calls and decks from 2017, newest first.
RepliCel Life Sciences Successfully Closes Financing
October 19, 2017
Streetwise Reports Interviews CJ Partners' Colin Lee Novick Who Says Japan is Fertile Ground for Biotech Deals
October 6, 2017
RepliCel Retains Hybrid Financial for Investor Relations
September 22, 2017
RepliCel's Partnership Initiatives Mature into Licensing Negotiations
September 13, 2017
RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal Injector
September 7, 2017
Streetwise Reports Examines Analyst's View that Cell Therapy Company's Move Decreases Risk
August 24, 2017
RepliCel Life Sciences Joins MedCision’s ThawSTAR® Early Adopter Program
August 16, 2017
Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical Data
August 10, 2017
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map
June 13, 2017
RepliCel CEO Provides Company Outlook
May 25, 2017
United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies
April 25, 2017
The Life Sciences Report Examines How Positive Trial Results Boost RepliCel's Profile
April 13, 2017
Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date
April 4, 2017
RepliCel's Successful RCT-01 Tendon Repair Clinical Trial Shows Signs of Healing Chronic Tendon Problems
March 28, 2017
The Life Sciences Report Examines RepliCel's Phase 1 Trial for Hair Loss Completed Successfully
March 17, 2017
RepliCel's Phase 1 Clinical Trial for Hair Loss Succeeds in Meeting Primary Endpoints
March 14, 2017
RepliCel Pursues Non-Diluting Grant Funding to Accelerate Value Creation and Commercialization
March 7, 2017
RepliCel Signs Two Key Service Partnerships for Final Prototype Manufacturing and Testing of its Dermal Injector
February 28, 2017
RepliCel Announces European Patents for its Innovative Dermal Injector Technologies
February 9, 2017
RepliCel Life Sciences Inc. announces Brokered Private Placement
February 7, 2017
RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors
February 3, 2017
The Life Sciences Report Examines Companies Flocking to Japan for Biotech Deals
February 2, 2017
RepliCel CEO Provides 2017 Forecast
January 5, 2017
Decks in 2017
- Investor Presentation (May 2017)
Investor deck · 34 slides · May 2017